secwatch.observer — SEC 8-K summary
======================================

Issuer:     SpringWorks Therapeutics, Inc. (—)
CIK:        0001773427
Form:       8-K
Filed at:   2024-02-27T23:59:59+00:00
Accession:  0001104659-24-027933
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SpringWorks enters up to $250M ATM equity offering program with Cowen
---------------------------------------------------------------------

- Sales Agreement with Cowen and Company allows sales of common stock up to $250 million aggregate offering price.
- Shares sold through Nasdaq or other existing trading markets; 3.0% commission paid to Cowen.
- Offering made under prior S-3 registration statement; prospectus supplement filed February 27, 2024.
- No minimum sales required; Agent uses commercially reasonable efforts based on Company instructions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1773427/000110465924027933/0001104659-24-027933-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1773427/000110465924027933/tm247273d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-027933

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer